Project Grant K08DK138319

Award Date 9/1/24
Completion Date 4/30/29
Dollars Obligated $510K
Federal Grant Program
93.847
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19104, USA
Similar Awards
This Project Grant award of $272,133 from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) supports research by the University of Pennsylvania on the role of lipid droplet proteins in regulating eicosanoid production and their impact on non-alcoholic fatty liver disease (NAFLD). The research aims to study common genetic variants in two lipid droplet proteins - PNPLA3-I148M and PLIN2-PRO251 - to...
This Project Grant award of $828,820 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research Program (CFDA 93.855) supports research to elucidate the molecular mechanisms by which the commensal bacterium Enterococcus faecalis can translocate across the intestinal epithelial barrier and cause systemic infections. The research aims to define how E. faecalis disrupts endoplasmic reticulum proteostasis and activates the unfolded...
This Project Grant award, valued at $643,700.00, was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The funding supports research by Cornell University to investigate the morphogenetic mechanisms governing the formation and function of the intestinal lymphatic smooth muscle-lacteal complex, which plays a critical role in dietary fat absorption and metabolism....
This Project Grant award of $1,508,800.00, provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research conducted by The University of Texas Southwestern Medical Center (UT Southwestern) to elucidate the role of somatic genetics in chronic liver disease pathways. The research aims to 1) identify adaptive genetic pathways specific to liver disease etiologies,...
This $626,429 Project Grant awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847) supports research to investigate the role of the carbohydrate responsive element binding protein (CHREBP) and its isoforms in liver metabolism and metabolic disorders. The project aims to resolve contradictory findings on CHREBP's effects and better understand its influence on conditions like metabolic-associated steatohepatitis, dyslipidemia, and cardiometabolic diseases....
This federal Project Grant award of $675,660.00 was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award was granted to the Beth Israel Deaconess Medical Center, Inc. (Bidmc) to conduct research focused on understanding the regulation and requirements for coenzyme A (CoA) biosynthesis, and how dysregulation of CoA synthesis is related to metabolic diseases...
This Project Grant award of $1,558,188 from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) will support research by the Zaret and Mir laboratories at the University of Pennsylvania and Children's Hospital of Philadelphia to investigate how changes in transcription factor and heterochromatin states impact liver development, homeostasis, and regeneration. The researchers will use advanced in vivo...
This federal Project Grant award of $1,255,725.00 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) aims to advance defined live biotherapeutic products (LBPs) for the treatment of recurrent Clostridioides difficile infection (rCDI) and ulcerative colitis. The key objectives are to: 1) Develop a solid-state fermentation platform to increase the scale and throughput of...
This federal Project Grant award, funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $747,500.00 to support research on memory formation in the enteric nervous system (ENS). The project aims to build the tools required for studying the formation and meaning of ENS memories, and then use these tools in combination with various perturbations to transform the...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $497,370 Project Grant (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) to the Regents of the University of Michigan. The grant, titled "CD45 MEDIATED REGULATION OF PMN FUNCTION DURING INTESTINAL INFLAMMATION", will fund research to determine the effects of neutrophil-specific loss of the CD45 tyrosine phosphatase on intestinal inflammation and repair processes. The...

This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) provides $510,060 to The Trustees of the University of Pennsylvania to conduct research on the role of the lac operon-dependent metabolism in Enterobacteriaceae and its impact on liver disease-associated infections. The key objectives are to characterize the mutations that enable Escherichia coli to metabolize lactulose, determine the competitive advantage of these mutations, and assess the impact of lactulose on disseminated infection in mouse and human models of liver disease. This 5-year project leverages novel techniques and resources, including a mouse model of disseminated infection and a human infection strain library, to advance understanding of the dietary and bacterial factors contributing to gastrointestinal diseases.

Generated 8/5/25, 5:19 AM